Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

everolimus

EU orphan designation number: EU/3/07/488
Active ingredient: everolimus
Indication: Treatment of gastro-entero-pancreatic neuroendocrine tumours
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/11/2007 Centralised Orphan - Designation EMEA/OD/040/07 (2007)5580 of 14/11/2007
18/07/2011 Centralised Orphan - Removal of orphan designation from Community Register